A Camptothecin-resistant DNA Topoisomerase I Mutant Exhibits Altered Sensitivities to Other DNA Topoisomerase Poisons
Open Access
- 1 March 1995
- journal article
- Published by Elsevier BV
- Vol. 270 (11), 6141-6148
- https://doi.org/10.1074/jbc.270.11.6141
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivativesBiochemistry, 1992
- DNA topoisomerases: Current Opinion in Structural Biology 1991, 1:99–103Current Opinion in Structural Biology, 1991
- Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activityJournal of Medicinal Chemistry, 1991
- DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in XenograftsScience, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- DNA topoisomerase-targeting antitumor drugs can be studied in yeast.Proceedings of the National Academy of Sciences, 1988
- Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogs. Structure-activity correlationsJournal of Medicinal Chemistry, 1987
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecinBiochemical and Biophysical Research Communications, 1971